drug
LUMISIGHT
updated 6mo agoby LUMICELL
community read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 1, 2030
~3.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Sep 14, 2034compositionUS 9763577
- Dec 8, 2031method-of-use (U-3890)US 10285759
- Dec 8, 2031method-of-use (U-3890)US 9032965
- Dec 8, 2031method-of-use (U-3890)US 9532835
- Oct 12, 2031method-of-use (U-3890)US 91554715.0y
- Sep 1, 2030compositionUS 115923963.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that